Curated dataset · n=61 verified deals · Not live market data · Scores are descriptive, not forecasts.
You are here

Deals — Network graph, deal flow, valuation matrix, and acquirer landscape.

Hamilton Thorne
→
Astorg

Acquisition · Cash · announced Jul 22, 2024

View in network
  1. Announced

    Jul 22, 2024

  2. Closed

    Dec 2, 2024

Economics

Cash()

Pre-deal · pre-deal mark: 2024, year precision · Astorg press release — Hamilton Thorne acquisition, 2024

C$10.50/share take-private; ~$282M equity value (Weil/Astorg announcement)

Target

Hamilton Thorne

Fertility · Fertility science

HQ Beverly, MA · Founded 1988

Precision laser devices, advanced imaging systems, consumables and software for assisted reproductive technology (ART) and IVF labs — products used in 115+ countries

  • Business Wire — Astorg press release (Dec 2, 2024)
  • Mergr M&A summary ($388M total)
  • Weil Gotshal advisory announcement ($282M)

Acquirer

Astorg

Fertility

HQ Luxembourg

Why this buyer

Curated copy from the verified dataset — not an 8-K LLM summary

Combined with Cook Medical RH to create global ART/IVF leader — precision laser instruments and advanced imaging serving 115+ countries

Evidence ladder

Press only — no primary filingValue disclosed
  1. Secondary (press / IR)

    Business Wire — Astorg press release (Dec 2, 2024)

  2. Tertiary (trade / analyst)

    Weil Gotshal advisory announcement (Jul 24, 2024)

Limitations

  • Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
  • C$10.50/share take-private; ~$282M equity value (Weil/Astorg announcement)
  • Pre-deal valuation sourced from: Astorg press release — Hamilton Thorne acquisition, 2024. Pre-deal market-cap and funding citations do not corroborate the acquisition.

Valuation peers · Fertility

Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer, until you sort.

Why included
Eugin Group (North American operations)KKR (via IVI-RMA)Nov 1, 2023same evidence class
Indira IVFBPEA EQTJul 28, 2023same evidence class
Modern FertilityRoMay 19, 2021value band

Same-sector adjacency — not valuation peers

These deals share the sector tag and window but sit outside the 0.25×–4× value band. The dataset keeps them for clinical adjacency, not as price comps.

Vs this deal
IVI-RMA GlobalKKRMar 1, 2022

Other verified deals by Astorg

Acquirer program history not already listed as a valuation peer or adjacency row.

No further verified deals

Other verified transactions by Astorg are already listed above, or none are in the dataset.

Patient empowerment context

Patient empowerment baseline (HLTH 2022)

No curated mapping — Hamilton Thorne (Fertility). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.

Research workspace (includes heuristic crosswalk) →

Related verified workspaces

Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.

Curated verified dataset v11 · updated 2026-10-19 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.